<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00746707</url>
  </required_header>
  <id_info>
    <org_study_id>feigenberg HMO-CTIL</org_study_id>
    <nct_id>NCT00746707</nct_id>
  </id_info>
  <brief_title>Biologic Glue for First Degree Perineal Tears</brief_title>
  <official_title>Randomized Control Trial for the Comparison of Biologic Glue Versus Suturing for First Degree Perineal Tears</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of octyl-2-cyanoacrylate adhesive glue is not inferior to traditional suturing for
      first degree perineal tears repair
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomized trial, comparing the use of octyl-2-cyanoacrylate adhesive
      glue to traditional suturing, for the repair of first degree perineal tears.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional and cosmetic evaluation of perineal tear area.</measure>
    <time_frame>At least six weeks after birth</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of pain at least six weeks after delivery</measure>
    <time_frame>At least six weeks after delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Grade 1 Perineal Tears</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>use of octyl-2-cyanoacrylate adhesive glue for perineal tear grade 1 in 80 women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>use of traditional suturing for perineal tear grade 1 in 50 women</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>1. Dermabond Topical Skin Adhesive 2-Octyl Cyanoacrylate</intervention_name>
    <description>adhesive of perineal tears</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>3. traditional suturing with vicryl rapid 2X0</intervention_name>
    <description>suturing of perineal tears grade one with vicryl rapid 2X0</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women after instrumental or normal vaginal delivery with a diagnosis of first degree
             perineal tears

        Exclusion Criteria:

          -  excessive bleeding,

          -  chronic steroid treatment,

          -  immunosuppressive treatment,

          -  active infection,

          -  allergy to Dermabond or Histoacryl
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>yosef ezra, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>hadassha medical organization, jerusalem israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2008</study_first_submitted>
  <study_first_submitted_qc>September 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2008</study_first_posted>
  <last_update_submitted>December 17, 2011</last_update_submitted>
  <last_update_submitted_qc>December 17, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hadassah Medical Organization</investigator_affiliation>
    <investigator_full_name>Ezra Yosi</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>adhesive glue, perineal tear, suture</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

